Cruciferous Vegetable Eating Program for Bladder Cancer
This study is testing a healthy eating program called POW-R Health to see if it can help reduce the chance of bladder cancer coming back (recurrence) or getting worse (progression) in people with early-stage bladder cancer. Researchers want to understand how eating more cruciferous vegetables, like broccoli or cauliflower, might help. You would participate in a behavioral dietary intervention, which involves learning how to increase your intake of these vegetables. The study will compare two versions of the POW-R Health program to see which is more effective. Success will be measured by changes in your urinary isothiocyanates (ITCs) levels, which are chemicals found after eating cruciferous vegetables. This study is for English-speaking adults aged 18 and older who live in New York State and have been diagnosed with certain types of early-stage bladder cancer.
- Study design
- This is an interventional study with a planned enrollment of 344 participants. It uses a 2-group randomized controlled trial (RCT) design.
- What's involved
- You would participate in a behavioral dietary intervention called POW-R Health Only/Core or POW-R Health + Maintenance. You would also receive live phone calls as part of a telephone-based intervention.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your urinary isothiocyanates (ITCs) levels will be measured at baseline and throughout the study, for up to 24 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
At a glance
Conditions
NCT06733363
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Roswell Park Comprehensive Cancer Center
Buffalo, New Yorkstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Karen Yeary, MD · PRINCIPAL_INVESTIGATOR · Roswell Park Comprehensive Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Urinary isothiocyanates (ITCs) levelsBaseline throughout life of study - up to 24 months
Levels with be measured using high performance liquid chromatography-based cyclocondensation assay